Literature DB >> 17575080

Development of lentiviral vectors with regulated respiratory epithelial expression in vivo.

Benjamin Hendrickson1, Dinithi Senadheera, Suparna Mishra, Kim Chi T Bui, Xingchao Wang, Belinda Chan, Denise Petersen, Karen Pepper, Carolyn Lutzko.   

Abstract

Development of gene transfer vectors with regulated, lung-specific expression will be a useful tool for studying lung biology and developing gene therapies. In this study we constructed a series of lentiviral vectors with regulatory elements predicted to produce lung-specific transgene expression: the surfactant protein C promoter (SPC) for alveolar epithelial type II cell (AECII) expression, the Clara cell 10-kD protein (CC10) for Clara cell expression in the airway, and the Jaagskiete sheep retrovirus (JSRV) promoter for expression in both cell types. Transgene expression from the SPC and CC10 vectors was restricted to AECII and Clara cell lines, respectively, while expression from the JSRV vector was observed in multiple respiratory and nonrespiratory cell types. After intratracheal delivery of lentivector supernatant to mice, transgene expression was observed in AECII from the SPC lentivector, and in Clara cells from the CC10-promoted lentivector. Transgene expression was not detected in nonrespiratory tissues after intravenous delivery of CC10 and SPC lentiviral vectors to murine recipients. In summary, incorporation of genomic regulatory elements from the SPC and CC10 genes resulted in respiratory specific transgene expression in vitro and in vivo. These vectors will provide a useful tool for the study of lung biology and the development of gene therapies for lung disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17575080      PMCID: PMC2176119          DOI: 10.1165/rcmb.2006-0276OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  48 in total

Review 1.  Adeno-associated virus-based gene therapy for inherited disorders.

Authors:  Terence R Flotte
Journal:  Pediatr Res       Date:  2005-12       Impact factor: 3.756

2.  In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector.

Authors:  D Nicole Worsham; Todd Schuesler; Christof von Kalle; Dao Pan
Journal:  Mol Ther       Date:  2006-08-07       Impact factor: 11.454

3.  Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.

Authors:  Patrick L Sinn; Erin R Burnight; Melissa A Hickey; Gary W Blissard; Paul B McCray
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia.

Authors:  R W Walters; T Grunst; J M Bergelson; R W Finberg; M J Welsh; J Zabner
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

5.  Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.

Authors:  Karlea L Kremer; Kylie R Dunning; David W Parsons; Donald S Anson
Journal:  J Gene Med       Date:  2007-05       Impact factor: 4.565

6.  Functional expression of mouse relaxin and mouse relaxin-3 in the lung from an Ebola virus glycoprotein-pseudotyped lentivirus via tracheal delivery.

Authors:  Josh D Silvertown; Jagdeep S Walia; Alastair J Summerlee; Jeffrey A Medin
Journal:  Endocrinology       Date:  2006-05-18       Impact factor: 4.736

7.  Gene transfer to respiratory epithelia with lentivirus pseudotyped with Jaagsiekte sheep retrovirus envelope glycoprotein.

Authors:  Patrick L Sinn; Andrea K Penisten; Erin R Burnight; Melissa A Hickey; Greg Williams; Diann M McCoy; Rama K Mallampalli; Paul B McCray
Journal:  Hum Gene Ther       Date:  2005-04       Impact factor: 5.695

8.  In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency.

Authors:  Denise A Carbonaro; Xiangyang Jin; Denise Petersen; Xingchao Wang; Fred Dorey; Ki Soo Kil; Melissa Aldrich; Michael R Blackburn; Rodney E Kellems; Donald B Kohn
Journal:  Mol Ther       Date:  2006-05-02       Impact factor: 11.454

Review 9.  Advances in noninvasive pulmonary gene therapy.

Authors:  Charles L Densmore
Journal:  Curr Drug Deliv       Date:  2006-01       Impact factor: 2.565

10.  Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction.

Authors:  Francesca Romana Santoni de Sio; Paolo Cascio; Anna Zingale; Mauro Gasparini; Luigi Naldini
Journal:  Blood       Date:  2006-02-09       Impact factor: 22.113

View more
  12 in total

1.  Lentivirus vector-mediated Rho guanine nucleotide dissociation inhibitor 2 induces beta-2 adrenergic receptor desensitization in β2AR desensitization mice model.

Authors:  Songshi Ni; Jing Zhao; Zhenxue Fu; Hua Liu
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

2.  Genetic modification of airway progenitors after lentiviral gene delivery to the amniotic fluid of murine fetuses.

Authors:  Suparna Mishra; Xingchao Wang; Nancy Smiley; Ping Xia; Chang Mu Hong; Dinithi Senadheera; Kim Chi Bui; Carolyn Lutzko
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-25       Impact factor: 6.914

3.  Targeted Type 2 Alveolar Cell Depletion. A Dynamic Functional Model for Lung Injury Repair.

Authors:  Orquidea Garcia; Michael J Hiatt; Amber Lundin; Jooeun Lee; Raghava Reddy; Sonia Navarro; Alex Kikuchi; Barbara Driscoll
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

4.  Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction.

Authors:  Denise A Carbonaro; Xiangyang Jin; Xingchao Wang; Xiao-Jin Yu; Nora Rozengurt; Michael L Kaufman; Xiaoyan Wang; David Gjertson; Yang Zhou; Michael R Blackburn; Donald B Kohn
Journal:  Blood       Date:  2012-07-25       Impact factor: 22.113

5.  Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.

Authors:  Yashodhar P Bhandary; Shwetha K Shetty; Amarnath S Marudamuthu; Hong-Long Ji; Pierre F Neuenschwander; Vijay Boggaram; Gilbert F Morris; Jian Fu; Steven Idell; Sreerama Shetty
Journal:  Am J Pathol       Date:  2013-05-08       Impact factor: 4.307

6.  Specific in vivo expression in type II pneumocytes of the Jaagsiekte sheep retrovirus long terminal repeat in transgenic mice.

Authors:  Raffy M Dakessian; Hung Fan
Journal:  Virology       Date:  2007-12-03       Impact factor: 3.616

7.  Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages.

Authors:  Andrew A Wilson; George J Murphy; Hiroshi Hamakawa; Letty W Kwok; Sreedevi Srinivasan; Avi-Hai Hovav; Richard C Mulligan; Salomon Amar; Bela Suki; Darrell N Kotton
Journal:  J Clin Invest       Date:  2009-12-21       Impact factor: 14.808

Review 8.  The a"MAZE"ing world of lung-specific transgenic mice.

Authors:  Emma L Rawlins; Anne-Karina Perl
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-28       Impact factor: 6.914

9.  Jaagsiekte sheep retrovirus biology and oncogenesis.

Authors:  Andrew Hofacre; Hung Fan
Journal:  Viruses       Date:  2010-12-03       Impact factor: 5.048

10.  Lentiviral vectors and cystic fibrosis gene therapy.

Authors:  Stefano Castellani; Massimo Conese
Journal:  Viruses       Date:  2010-01-29       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.